. 2020 Jul 28;7(3):29–38. doi: 10.1530/ERP-20-0009
This work is licensed under a Table 3.
Baseline characteristics and echocardiographic parameters of the patients according to the type of valve used in the TAVI procedure.
| Characteristics and parameters | Edwards S3 | Evolut R | P-value |
|---|---|---|---|
| n | 51 (60%) | 34 (40%) | |
| Euroscore (%) | 8.04 ± 4.4 | 9.5 ± 5.7 | 0.291 |
| Age (years) | 81.29 ± 8.21 | 79.67 ± 8.29 | 0.246 |
| Female, n (%) | 29 (64.4) | 16 (35.5) | 0.291 |
| BSA (m2) | 1.72 ± 0.15 | 1.77 ± 0.14 | 0.128 |
| Bundle branch block, n (%) | 8 (15.7) | 8 (23.5) | 0.823 |
| Pacemaker, n (%) | 5 (9.8) | 4 (11.8) | 0.521 |
| Hypertension, n (%) | 31 (60.8) | 22 (64.7) | 0.715 |
| Lung disease, n (%) | 18 (35.3) | 11 (32.4) | 0.779 |
| CKD, n (%) | 12 (23.5) | 9 (26.5) | 0.758 |
| Diabetes mellitus, n (%) | 8 (15.7) | 6 (17.7) | 0.518 |
| Hyperlipidemia, n (%) | 16 (55.7) | 13 (44.8) | 0.513 |
| AVA (cm2) | 0.67 ± 0.19 | 0.72 ± 0.16 | 0.407 |
| MG (mmHg) | 45.16 ± 15.63 | 44.18 ± 16.06 | 0.781 |
| PG (mmHg) | 81.22 ± 26.94 | 79.33 ± 28.98 | 0.756 |
| LVEDD (cm) | 4.46 ± 0.62 | 4.43 ± 0.63 | 0.499 |
| IVSD (cm) | 1.3 ± 0.29 | 1.26 ± 0.29 | 0.327 |
| PWT (cm) | 1.23 ± 0.23 | 1.19 ± 0.27 | 0.186 |
| LVESD (cm) | 3.03 ± 0.70 | 2.98 ± 0.79 | 0.577 |
| FS (%) | 32.4 ± 8.8 | 33.2 ± 1.01 | 0.449 |
| RWT | 0.57 ± 0.16 | 0.55 ± 0.19 | 0.584 |
| SV (mL) | 67.94 ± 19.27 | 73.24 ± 18.78 | 0.147 |
| LVMi (g/m2) | 124.4 ± 43.3 | 113.4 ± 31.6 | 0.184 |
| EF (%) | 47.5 ± 15.2 | 47.8 ± 15.2 | 0.523 |
| E/A ratio | 0.86 ± 0.60 | 0.88 ± 0.43 | 0.120 |
| E/e′ ratio | 16.48 ± 7.7 | 15.62 ± 7.94 | 0.465 |
| GLS (%) | −13.08 ± 4.85 | −15.26 ± 5.26 | 0.07 |
AVA, AV area; BSA, body surface area; CKD, chronic kidney disease; FS, fractional shortening; IVSD, interventricular septum diameter; LVEDD, LV end-diastolic diameter; LVESD, LV end-systolic diameter; LVMi, LV mass indexed to body surface area; MG, mean gradient; PG, peak gradient; PWT, posterior wall thickness; RWT, relative wall thickness; SV, stroke volume.